Jacobs Levy Equity Management
TIL icon

Jacobs Levy Equity Management’s Instil Bio TIL Stock Holding History

Jacobs Levy Equity Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-43,364
Closed -$371K – 1080
2023
Q3 		$371K Buy
43,364
+32,677
+306% +$329K ﹤0.01% 852
2023
Q2 		$118K Buy
+10,687
New +$131K ﹤0.01% 943

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management's TIL Position: Q4 2023 in Review

Jacobs Levy Equity Management sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 43,364 shares — an estimated $371K sold.

Jacobs Levy Equity Management first reported a position in TIL in Q2 2023 and held it in 2 quarters. The position peaked at $371K in Q3 2023. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

  • Jacobs Levy Equity Management reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 43,364 Instil Bio shares in Q4 2023, an estimated $371K.
  • Jacobs Levy Equity Management first reported a position in Instil Bio in Q2 2023 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Instil Bio position peaked at $371K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.